Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer
US9011865B2 · kind B2 · utility
3Cited by
0References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 3, 2013 |
| Grant date | Apr 21, 2015 |
| Priority date | — |
| Expiry date | Dec 3, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention also relates to a composition comprising an antibody antagonist to c-Met and an aminoheteroaryl compound, particularly as a medicament. The present invention also comprises a pharmaceutical composition comprising said anti c-Met antibody and said aminoheteroaryl compound as combination products for simultaneous, separate or sequential use. The invention relates to the use of the composition of the invention for the treatment of cancer in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.